Geron Company Description

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies.

It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis.

The company was incorporated in 1990 and is headquartered in Foster City, California.

Geron Corporation

Country	United States
Founded	1990
Industry	Biological Products, Except Diagnostic Substances
Employees	229
CEO	John Scarlett

Contact Details

Address: 919 East Hillsdale Boulevard Foster City, Delaware 94404 United States
Phone	650 473 7700
Website	geron.com

Stock Details

Ticker Symbol	GERNW
Exchange	OTCMKTS
Stock Type	Warrants
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2836

Key Executives

Name	Position
John Scarlett	Chief Executive Officer
Michelle Robertson	Chief Financial Officer
Andrew Grethlein	Chief Operating Officer
Aron Feingold	Head of Investor Relations